ApprovalTrail

Approval · Notice of Compliance 16438 · 2014

RABAVERT: Notice of Compliance 16438

Issued December 17, 2014

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
16438
Date
December 17, 2014
Product type
Biologic
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Changes in manufacturing process
Therapeutic class
Active immunizing agent

Products in this notice

BrandDINStatus today
RABAVERTNot yet assigned—

Medicinal ingredients